已收录 268921 条政策
 政策提纲
  • 暂无提纲
Bioresponsive drug delivery systems for the treatment of inflammatory diseases
[摘要] A Inflammation is intimately related to the pathogenesis of numerous acute and chronic diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and neurodegenerative diseases. Therefore antiinflammatory therapy is a very promising strategy for the prevention and treatment of these inflammatory diseases. To overcome the shortcomings of existing anti-inflammatory agents and their traditional formulations, such as nonspecific tissue distribution and uncontrolled drug release, bioresponsive drug delivery systems have received much attention in recent years. In this review, we first provide a brief introduction of the pathogenesis of inflammation, with an emphasis on representative inflammatory cells and mediators in inflammatory microenvironments that serve as pathological fundamentals for rational design of bioresponsive carriers. Then we discuss different materials and delivery systems responsive to inflammation-associated biochemical signals, such as pH, reactive oxygen species, and specific enzymes. Also, applications of various bioresponsive drug delivery systems in the treatment of typical acute and chronic inflammatory diseases are described. Finally, crucial challenges in the future development and clinical translation of bioresponsive anti-inflammatory drug delivery systems are highlighted.
[发布日期] 2020-11-10 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Bioresponsive materials;Reactive oxygen species;Drug delivery;Inflammatory diseases;Nanoparticles;Microparticles;Hydrogels [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文